<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26052">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767609</url>
  </required_header>
  <id_info>
    <org_study_id>5140083</org_study_id>
    <nct_id>NCT02767609</nct_id>
  </id_info>
  <brief_title>Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging</brief_title>
  <official_title>Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test a new MRI sequence that measures cerebral blood flow (CBF). Because
      this technique for measuring CBF is new, there is little information on what the normal
      values for different regions of the brain should be. Information from the study will be used
      to establish normative CBF values for the brain, improving the reliable use of this
      technique for the diagnosis of brain injury or disease.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regional cerebral blood flow values of the brain measured using pseudo-continuous arterial spin labeling (pCASL) MRI.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Multiple Sclerosis</condition>
  <condition>Alzheimer's Disease</condition>
  <condition>Tumor</condition>
  <arm_group>
    <arm_group_label>Magentic Resonance Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>magnetic Resonance Imaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>All participants will have be given a MRI using a pseudo-continuous arterial spin labeling perfusion sequence.</description>
    <arm_group_label>Magentic Resonance Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any person between the ages of 18-90 years, who is undergoing routine magnetic
             resonance imaging (MRI) of the head with or without contrast at Loma Linda University
             Medical Center.

          -  Must be eligible for MRI (no electronic or metal implants that are not MR
             compatible).

        Exclusion Criteria:

          -  Electronic or metal implant that is not MRI safe, pregnancy or claustrophobia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brenda Bartnik Olson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Medical Center</affiliation>
  </overall_official>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 9, 2016</lastchanged_date>
  <firstreceived_date>May 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Brenda Bartnik Olson, PhD</investigator_full_name>
    <investigator_title>Associate Proffesor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
